Synthesis of the desired spirooxindole 4a-k.

 
 
  Part of: Sammor MS, Habashneh AY, Al-Sha'er MA, Bardaweel SK, El‐Abadelah MM (2025) Novel spirooxindole compounds as anticancer agents: targeting Plk4 kinase through design, synthesis, and molecular docking. Pharmacia 72: 1-13. https://doi.org/10.3897/pharmacia.72.e149240